ACCESS GROWTH CAPITAL THROUGH THE PUBLIC MARKETS

TSX and TSX Venture Exchange list leading public Life Sciences companies from Canada and around the world.

Dani Lipkin

Dani Lipkin

Managing Director, Global Innovation Sector
Toronto Stock Exchange and TSX Venture Exchange

LIFE SCIENCES Updates

A collection of videos focused on insights for accessing growth capital through the public markets with industry experts.

KEY BENEFITS FOR LIFE SCIENCES COMPANIES

  • 1
    Access To Capital And Future Financing Opportunities
    Going public can provide your company with financing opportunities to grow your business while expanding and diversifying your investor base by giving you access to pools of capital in Canada, the U.S. and globally.
  • 2
    Facilitate Growth
    As a public company, your shares can be used as a currency substitute to acquire target companies, instead of a direct cash offering.
  • 3
    Increase Visibility And Prestige
    Going public enhances your company’s visibility which can provide your company with a higher profile and greater credibility.
  • 4
    Provide Liquidity For Shareholders
    Becoming a public company establishes a market for your company’s shares, providing your investors with an efficient and regulated vehicle in which to trade their shares.
  • 5
    Create Employee Incentive Mechanisms
    Your employees can participate in the ownership of your company and benefit from being shareholders. This can serve to ensure stronger employee commitment to your company’s performance and success.

$26 billion

in market capitalization

53%

of Life Sciences companies currently listed on TSX are graduates
Subscribe to our Quarterly Life Sciences newsletter

Get the latest Life Sciences news, listings, upcoming events, and more to your inbox.

WHY GO PUBLIC?

CAPITAL SOLUTIONS

For early-stage companies looking to gain access to public venture capital - or larger, established companies looking to take their business to the next level, going public may be the right fit for your company. Our two-tiered market offers financing and liquidity solutions that can be as unique as the businesses it serves.

GO PUBLIC - WAYS TO GET LISTED

There are multiple pathways to listing on TSX and TSXV.

TSX and TSXV Listed company initiatives

TSX30

TSX30™ is a ranking of the top 30 performers on Toronto Stock Exchange over a three-year period. As our flagship program, it offers unique insight into important market trends, and shines a light on compelling companies driving progress across industries and around the world.

TSX VENTURE 50

The TSX Venture 50 is a ranking of the top ten performers on the TSX Venture Exchange over the last year, comprising of 10 companies from five industry sectors.

This annual program showcases the top performing listed companies from five industry sectors, including: Clean Technology and Life Sciences, Diversified Industries, Energy, Mining, and Technology. Selection is based on 3 equally weighted criteria: share price appreciation, trading volume, and market capitalization growth.

Life Sciences Statistics

12

new Life Sciences listings
in 2022

$1.8 billion

Life Sciences equity capital raised
in 2022

83

Life Sciences financings
in 2022

All data as of December 31, 2022.

Market Intelligence Report (MiG)

Provides year-to-date data on listings, financings and trading activity across Toronto Stock Exchange and TSX Venture Exchange, broken down by sector and region.

GET OUR MIG REPORT

LEARN ABOUT TSX AND TSXV

WHAT INDUSTRY EXPERTS ARE SAYING
TMX Presents: The Podcast - Ep. 013: Bloom Burton & Co’s Brian Bloom on the Canadian Healthcare Sector
TSX’s Daniel Lubienietzky speaks with Bloom Burton & Co’s Chairman and CEO, Brian Bloom about the Canadian healthcare investing landscape. Hear how Brian Bloom’s degrees in biochemistry and biological sciences, coupled with his stints at various New York investment banking firms, laid the foundation of his success in co-founding Bloom Burton & Co. Brian Bloom also highlights many of the strengths of Canada’s healthcare investment ecosystem and gives a unique perspective on where things are going.
Read more
TMX POV - Canadian Life Sciences Market is Alive and Flourishing
In many ways, 2020 started out quite optimistically for Canadian markets -- according to Statistics Canada unemployment was at a five-year low of 5.6% at the end of 2019 and the S&P/TSX Composite Index* had a very robust 22% return from the previous year. All signs seemed to point to continued momentum into 2020.
Read more

More Info

Dual-Listing Guide

Dual-Listing Guide

A detailed guide for public companies looking to dual list.

2023 Guide to Listing

2023 Guide to Listing

Market overview, listing requirements & vehicles, and sector profiles.

Technical Guide

Technical Guide

A more detailed guide to listing on TSX and TSXV.